从医疗科技到健康科技：赋能未来健康护理生态系统

Empowering the FutureWELLcare Ecosystem Contacts Global United StatesJames Woods China Body textAnthony BruceGlobal HealthIndustries LeaderPartner, PwC UK+44-7801-916-767anthony.bruce@pwc.com Partner,Strategy& US+1-6177-847-852james.woods@pwc.com Jia Xu (Ph.D.)Partner, Strategy& China+86-10-6533-7734jia.x.xu@strategyand.cn.pwc.com JapanShunsuke Horii Asia Pacific HealthIndustries LeaderPartner, PwC Japan+81-8033-176-966shunsuke.s.horii@pwc.com Europe Dr. Thomas SolbachPartner and ManagingDirector, Strategy& Germany+49-170-2238-477thomas.solbach@pwc.com Roland WernerHealth Industries LeaderGermanyPartner, PwC Germany+49-170-7628-557roland.m.werner@pwc.com United KingdomThalita Marinho Partner, Strategy& UK+44-790-016-3439thalita.marinho@pwc.com India Dr. Till GiesePartner, Strategy& Germany+49-151-5593-2042till.giese@pwc.com Sujay ShettyPartner, PwC India+91-98677-00030sujay.shetty@pwc.com Harald DutzlerRetail and Consumer LeaderEuropePartner, Strategy& Austria+43-664-515-2904harald.dutzler@pwc.com ABOUT THE AUTHORS Body textDr. Thomas Solbachadvises clients in the healthcare and life sciences industry globally. Hespecializes in helping biopharma, diagnostics, MedTech and digital health solution providersto develop and implement differentiated strategies, capabilities, innovations, and resilientoperating models with a particular focus on precision medicine. He leads Strategy&’s Europeanpharma and life sciences practice. Based in Frankfurt, he is a Partner with Strategy& Germany. Dr. Till Gieseis a Partner at Strategy& Germany, based in Hamburg. He advises internationalclients from the pharmaceutical, MedTech, and healthcare industries. With more than 18 yearsof industry experience, he specializes in strategy development and implementation, large scaletransformations, innovation, digitization, and operational excellence. With this, he aims to leadclients to sustainable growth. Oliver Dolnyis a Senior Manager at Strategy& Germany, where he supports clients in the MedTechand pharmaceutical industries on strategy development, transformation programs, and operatingmodel design. With more than 15 years of consulting and industry experience, Oliver – working out ofthe Munich office – helps organizations address structural challenges and unlock long-term growth. Rahul Khatriis a Senior Associate at Strategy& Germany, where he works with clients acrossPharma, Life Sciences, and MedTech on strategy, enterprise transformation, and operatingmodel design. Located in Munich, he combines his consulting background with several years asa clinical pharmacist to help clients build future-ready businesses aligned with the evolvinghealthcare and life sciences landscape. Lukas Rojahn, Senior Associate and Jonas Pütter, Associate at Strategy& Germany, alsocontributed to this report. INTRODUCTION $850 billion annually – that is the estimated market potential of WellTechacross the United States, the European Union, and the United Kingdom.But what exactly is WellTech, and why is it poised to redefine the futureof health? Healthcare is undergoing a profound transformation – moving from a system focused ontreatment and disease management to one that empowers individuals to sustain lifelongwell-being. The boundaries between clinical care and everyday life are dissolving, giving riseto a consumer-centric model defined by personalization, prevention, and empowerment.This evolution marks the emergence of a new category within MedTech: WellTech. WellTech represents a new generation of technologies designed not only to treat illness, but tosustain health. Powered by data, connectivity, and Artificial Intelligence (AI), WellTechsolutions enable consumers to actively manage their well-being while providing healthcaresystems with continuous, real-world insights. From wearables tracking sleep, stress, andactivity to AI-driven platforms offering personalized guidance, WellTech is transforming healthmanagement from a reactive process into a proactive, everyday experience. This study explores how the convergence of consumer technology, MedTech, and dataecosystems is reshaping the future of health. Drawing on insights from 1,500 consumersacross the United States, the United Kingdom, and Germany, as well as interviews withindustry leaders, our analysis reveals a growing demand for accessible, evidence-based,and trusted preventive solutions. According to our survey, more than 95% of consumersexpress interest in using at least one WellTech solution in the future, highlighting the stronggrowth potential of this emerging market.1 The implications are far-reaching. Health systems are transitioning from a disease-centeredmodel to a LIFEcare ecosystem that integrates prevention, early detection, and continuousoptimization as core elements of both care delivery and daily living. In response, companiesmust adapt their business models, forge cross-industry partnerships, and leverage data-driven innovation. Trust, privacy, and clin